ArticlePlant molecular biology2026
A synthetic expression system for orthogonal gene expression in Nicotiana benthamiana.
Article in Plant molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plants represent commercially relevant production systems for recombinant proteins and chemical compounds. Effective genetic engineering depends on precise control of heterologous gene expression, which remains challenging due to complex transcriptional and post-transcriptional regulation, endogenous gene silencing mechanisms, and notably because of limited number of tools for allowing robust, fine-tuned control of expression levels across different systems/organisms. Some of the most common issues associated with plant expression systems are addressed with our plant-optimized version of a previously developed fungal universal synthetic expression system (SES). Plant SES demonstrates several favorable characteristics for robust heterologous gene expression, including highly constitutive function with apparently reduced sensitivity to endogenous silencing in transient assays, without requiring p19 co‑expression under the tested conditions. These together provide simple, predictable tuning of gene expression levels, and the potential for very high expression levels of the target genes. In all these features, SES shows higher and more stable transcript levels than Cauliflower Mosaic Virus (CaMV) 35 S promoter-based constructs in our experimental setups. The functionality of plant SES was tested by expressing mCherry and three commercially relevant proteins: fungal glucose oxidase (GOX), protein A and human vascular endothelial growth factor 165 (VEGF16) from diverse organisms, supporting high-level accumulation of recombinant proteins. In addition, plant SES retains full functionality in both plant and fungal hosts, which makes this expression system a useful tool for a multitude of genetic engineering applications in other eukaryotic organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.